EQUASENS |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.3 EUR | +0.84% |
|
+2.55% | -1.31% |
| Apr. 02 | Equasens : RNPG virtually stable in 2023 | CF |
| Mar. 29 | Equasens Société Anonyme Provides Revenue Guidance for the 2025 | CI |
Business Summary
- pharmacy software publishing and integration (73%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.;
- publishing of IT solutions for health and medical/social establishments (15.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.);
- development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo).
Net sales are distributed geographically as follows: France (90.9%), Italy (4.9%), Belgium and Luxembourg (2.7%), Ireland and the United Kingdom (0.8%) and Germany (0.7%).
Sales per Business
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
Pharmagest
73.0
%
| - | - | 156 | 73.0 % | - |
Axigate Link
15.2
%
| - | - | 33 | 15.2 % | - |
Others
11.8
%
| - | - | 25 | 11.8 % | - |
Sales per region
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
France
90.9
%
| 175 | 90.5 % | 194 | 90.9 % | +11.26% |
Italy
4.9
%
| 10 | 4.9 % | 10 | 4.9 % | +9.17% |
Belgium
2.6
%
| 3 | 1.6 % | 6 | 2.6 % | +85.05% |
Germany
0.8
%
| 1 | 0.7 % | 2 | 0.8 % | +16.50% |
United Kingdom
0.7
%
| - | - | 2 | 0.7 % | - |
Ireland
0.1
%
| - | - | 0 | 0.1 % | - |
Luxembourg
0.0
%
| - | - | 0 | 0.0 % | - |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 90-12-31 | |
Thierry Chapusot
FOU | Founder | 65 | 96-01-24 |
| Director of Finance/CFO | - | 22-12-31 | |
Damien Maringer
CTO | Chief Tech/Sci/R&D Officer | - | 18-06-30 |
| Director/Board Member | 53 | 20-06-28 | |
| Director/Board Member | 59 | 99-12-31 | |
Sabrina Gharbi
HRO | Human Resources Officer | - | 18-12-31 |
Erwan Salque
PRN | Corporate Officer/Principal | - | - |
| Corporate Officer/Principal | - | - | |
Liza Natan
PRN | Corporate Officer/Principal | 50 | 05-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Thierry Chapusot
FOU | Founder | 65 | 96-01-24 |
| Director/Board Member | 46 | 17-06-26 | |
| Director/Board Member | 59 | 99-12-31 | |
Daniel Antoine
BRD | Director/Board Member | 72 | 01-12-31 |
Anne Lhote
BRD | Director/Board Member | 55 | 11-06-15 |
| Chief Executive Officer | 55 | 90-12-31 | |
| Director/Board Member | 60 | 22-05-31 | |
François Jacquel
BRD | Director/Board Member | 65 | 10-12-31 |
Sophie Mayeux
BRD | Director/Board Member | 66 | 12-06-21 |
Emilie Lecomte
BRD | Director/Board Member | 45 | 17-06-26 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 15,174,125 | 4,921,426 ( 32.43 %) | 140,844 ( 0.9282 %) | 32.43 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
EQUASENS 0.94% | 142,428 | 0.94% | 7,891,081 $ |
Company contact information
Equasens
5, Allée de Saint-Cloud Technopole de Nancy Brabois
54600, Villers-lès-Nancy
+33 3 83 15 95 95
http://equasens.com
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
59.8
EUR
Average target price
71.25
EUR
Spread / Average Target
+19.15%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.31% | 962M | |
| -9.75% | 199B | |
| +0.99% | 168B | |
| +11.40% | 167B | |
| +5.94% | 101B | |
| +7.56% | 78.31B | |
| +17.36% | 72.48B | |
| -7.27% | 71.7B | |
| -23.97% | 50.48B | |
| +0.90% | 48.34B |
- Stock Market
- Equities
- EQS Stock
- Company Equasens
